These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3352536)

  • 1. Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy.
    Rogers P; Hill I; Sinclair-Smith C; Bowie M
    Med Pediatr Oncol; 1988; 16(2):128-31. PubMed ID: 3352536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
    Shih LY; Liaw SJ; Dunn P; Kuo TT
    J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
    Nair S; Mathan M; Ramakrishna BS; Mathan VI
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-Hodgkin's lymphoma. Results of a therapeutic protocol].
    Verdeguer A; Castel V; Mínguez JR; Ferris J
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():130-2. PubMed ID: 3214020
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Real Life' experience in a 'difficult to treat' patient population of non-Hodgkin lymphomas using the R-COMP regimen.
    Annibali O; Chiodi F; Cenfra N; Sarlo C; Mega S; Cavallari I; Rago A; Tomassini S; Mecarocci S; Cimino G; Avvisati G
    Leuk Lymphoma; 2016 Dec; 57(12):2919-2922. PubMed ID: 27063923
    [No Abstract]   [Full Text] [Related]  

  • 6. Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease.
    Hubmann R; Kaiser W; Radaszkiewicz T; Fridrik M; Zazgornik I
    Z Gastroenterol; 1995 Apr; 33(4):209-13. PubMed ID: 7793120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.
    Barista I; Tekuzman G; Firat D; Baltali E; Kansu E; Kars A; Ozisik Y; Ruacan S; Uzunalimoğlu B; Karaağaoğlu E
    Jpn J Cancer Res; 1994 Dec; 85(12):1200-7. PubMed ID: 7531679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of Mediterranean abdominal lymphoma. Retrospective comparison of chemotherapy protocols in Iranian patients.
    Salimi M; Spinelli JJ
    Am J Clin Oncol; 1996 Feb; 19(1):18-22. PubMed ID: 8554029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of the treatment of 46 non-Hodgkin's lymphomas in children].
    Zubeldia Sánchez J; Bezanilla Regato JL; Navajas Gutiérrez A; Burgos J; Moya Calderón E
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():133-7. PubMed ID: 3214021
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.
    Adams HJA; Kwee TC
    Ann Hematol; 2018 Apr; 97(4):719-720. PubMed ID: 29222579
    [No Abstract]   [Full Text] [Related]  

  • 12. CHOP versus m-BACOD in non-Hodgkin's lymphoma.
    Hryniuk W
    N Engl J Med; 1993 Feb; 328(8):581. PubMed ID: 7678920
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
    Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
    Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
    Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
    Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical investigations in aggressive non-Hodgkin lymphoma.
    Jonathan F
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
    [No Abstract]   [Full Text] [Related]  

  • 16. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.
    Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S
    Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we suppress the antigenic stimulus in IPSID for lifelong?
    Celik AF; Pamuk GE; Pamuk ON; Uzunismail H; Oktay E; Doğusoy G
    Am J Gastroenterol; 2000 Nov; 95(11):3318-20. PubMed ID: 11095373
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary non-Hodgkin,s lymphoma of the uterine cervix.
    Hanprasertpong J; Hanprasertpong T; Thammavichit T; Kongkabpan D; Tungsinmunkong K; Chandeying N
    Asian Pac J Cancer Prev; 2008; 9(2):363-6. PubMed ID: 18712992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
    Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
    Santhosh-Kumar CR; Ajarim DS; Shipkey FD
    Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.